Skip to main content

Flu Vaccine Uptake Varies by Sociodemographic Factors in CKD Patients

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

TUESDAY, Sept. 26, 2023 -- Among patients with chronic kidney disease (CKD), younger adults, Black individuals, and those with adverse social determinants of health are less likely to receive a flu vaccine, according to a study published online Sept. 15 in the American Journal of Kidney Diseases.

Junichi Ishigami, M.D., from the Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues identified risk factors for not receiving an influenza vaccine ("nonvaccination") among people with CKD. The analysis included 3,692 participants in the Chronic Renal Insufficiency Cohort Study.

The researchers found that between 2009 and 2020, the pooled mean vaccine uptake was 72 percent. Factors significantly associated with influenza nonvaccination were younger age (adjusted prevalence ratio [aPR], 2.16 for <50 versus ≥75 years), Black race (aPR, 1.58 versus White race), lower education (aPR, 1.20 for less than high school versus college graduate), lower annual household income (aPR, 1.26 for <$20,000 versus >$100,000), formerly married status (aPR, 1.22 versus currently married), and nonemployed status (aPR, 1.13 versus employed). Nonvaccination status was less likely among participants with diabetes (aPR, 0.80), chronic obstructive pulmonary disease (aPR, 0.80), end-stage kidney disease (aPR, 0.64 versus estimated glomerular filtration rate ≥60 mL/min/1.73 m2), frailty (aPR, 0.86), and ideal physical activity (aPR, 0.90 versus physically inactive).

"Importantly, nephrology care may represent an important opportunity to increase vaccine uptake in patients with CKD by leveraging trusted relationships between nephrologists and patients," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted September 2023

Read this next

COVID-19 Vaccination Not Tied to Adverse Pregnancy Outcomes

TUESDAY, June 25, 2024 -- mRNA COVID-19 vaccination during pregnancy is not associated with an increased risk of adverse pregnancy outcomes, according to a study published in the...

FDA Approves Capvaxive Pneumococcal 21-Valent Conjugate Vaccine

FRIDAY, June 21, 2024 -- The U.S. Food and Drug Administration has approved the Capvaxive pneumococcal 21-valent conjugate vaccine for the prevention of invasive pneumococcal...

No Evidence That Live Vaccines Are Unsafe for Patients on Dupilumab

FRIDAY, June 14, 2024 -- There is no evidence to suggest that administration of live vaccines to patients receiving dupilumab is unsafe, and vaccine efficacy is not affected by...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.